COVID-19 Vaccine Emergency Authorisation in India Possible
--Must See--

Bioinformatics Summer Internship 2024 With Hands-On-Training + Project / Dissertation - 30 Days, 3 Months & 6 Months Duration

COVID-19 Vaccine Emergency Authorisation in India Possible: ICMR

A top ICMR official told a parliamentary panel that emergency authorization of a COVID-19 vaccine could be considered if the Centre decides so as the phase-two clinical trials of two indigenously developed COVID-19 vaccine candidates have almost been completed.

An MP present in the meeting said that the Indian Council of Medical Research (ICMR) Director-General, Balram Bhargava informed members of the parliamentary standing committee on home affairs that the vaccine candidates developed by the Serum Institute of India, Zydus Cadila, and Bharat Biotech are at different stages of trials.

The COVID-19 vaccine candidates coordinated by Zydus Cadila and Bharat Biotech are nearing completion of phase-two trails.

The MP said, around 1,700 patients have been identified at 17 centers across the country for the phase-2 (b) trials this weekend for the vaccine handled by the Serum Institute of India and developed by Oxford University.

Bhargava, responding to the queries by the panel, informed that taking samples from gargled water is already under consideration and further details will be available soon when asked about the saliva test cleared by the FDA in the US for rapid detection of SARS-CoV-2.

The parliamentary committee members complimented

the medical fraternity in general and the ICMR in particular for their committed role in fighting the pandemic.

An MP in the panel said that ICMR agreed to the panel members’ suggestion of reviewing the existing limited set of guidelines relating to the management of psychological stress while discussing the mental stress among the people due to the pandemic. To help all the concerned to cope with the stress caused by the outbreak of the viral disease, ICMR also told the committee that it may soon come out with comprehensive revised guidelines.

The meeting, chaired by Anand Sharma, the senior Congress leader, and Rajya Sabha MP, discussed various aspects of management of the COVID-19 pandemic and also its impact on the micro, small and medium enterprises (MSME) sector, and it lasted for over four hours

Source
COVID-19 Vaccine Emergency Authorisation in India Possible: ICMR